2 results for " ISSN:"0114-5916" AND Volume:18 AND PageRange:161 "   Not what you’re looking for? Try Advanced Search

A risk-benefit assessment of treatment with finasteride in benign prostatic hyperplasia.

Ekman, P.
Drug safety. Volume 18; Issue 3; Pages 161-70; 1998
Type:   Journal Article;  Review

As an androgen target organ, the prostate gland has the almost unique characteristic of being less sensitive to testosterone than to its metabolite 5 alpha-dihydrotestosterone (5 alpha-DHT). The conversion of testosterone to 5 alpha-DHT is induced by...
 Abstract


A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia

Ekman, Peter
Drug Safety. Volume 18; Issue 3; Pages 161-170; 1998
Type:   Review